3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Sell
48
LTGHY Quote, Financials, Valuation and Earnings
Last price:
$3.54
Seasonality move
:
3.27%
Day range:
$3.46 - $3.58
52-week range:
$2.05 - $4.60
Dividend yield:
3.12%
P/E ratio:
5.05x
P/S ratio:
0.93x
P/B ratio:
1.74x
Volume:
102.1K
Avg. volume:
94.5K
1-year change:
-8.29%
Market cap:
$1.3B
Revenue:
$1.4B
EPS (TTM):
$0.70
Analysts' Opinion
-
Consensus RatingLife Healthcare Group Holdings has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Life Healthcare Group Holdings has an estimated downside of -- from its current price of $3.54.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $3.54.
Fair Value
-
According to the consensus of 0 analysts, Life Healthcare Group Holdings has -- downside to fair value with a price target of -- per share.
LTGHY vs. S&P 500
-
Over the past 5 trading days, Life Healthcare Group Holdings has overperformed the S&P 500 by 1% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Life Healthcare Group Holdings does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Life Healthcare Group Holdings has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Life Healthcare Group Holdings reported revenues of --.
Earnings Growth
-
Life Healthcare Group Holdings has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Life Healthcare Group Holdings reported earnings per share of --.
Enterprise value:
1.4B
EV / Invested capital:
--
Price / LTM sales:
0.93x
EV / EBIT:
8.04x
EV / Revenue:
1.00x
PEG ratio (5yr expected):
0.03x
EV / Free cash flow:
11.45x
Price / Operating cash flow:
10.66x
Enterprise value / EBITDA:
5.73x
Gross Profit (TTM):
$968.5M
Return On Assets:
14.22%
Net Income Margin (TTM):
18.67%
Return On Equity:
30.26%
Return On Invested Capital:
21.51%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-07 | 2024-01-07 | 2024-01-07 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $435.3M | $487.7M | $431.5M | $1.5B | $440.2M | |
| Total Assets | $2.5B | $2.7B | $2.3B | $2.4B | $1.4B | |
| Current Liabilities | $583.7M | $485.9M | $424M | $589.6M | $307.9M | |
| Total Liabilities | $1.4B | $1.4B | $1.2B | $1.3B | $632.7M | |
| Total Equity | $1.1B | $1.3B | $1.1B | $1.1B | $789.5M | |
| Total Debt | $766.6M | $657M | $620.3M | $635.7M | $191.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-07 | 2024-01-07 | 2024-01-07 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
LTGHY
Sector
Market Cap
$1.3B
--
Price % of 52-Week High
76.96%
--
Dividend Yield
3.12%
--
Shareholder Yield
55.03%
--
1-Year Price Total Return
-8.29%
--
Beta (5-Year)
0.804
--
Dividend yield:
3.12%
Annualized payout:
$1.39
Payout ratio:
203.01%
Growth streak:
1 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$3.45
200-day SMA
Buy
Level
$3.20
Bollinger Bands (100)
Sell
Level
3.29 - 3.85
Chaikin Money Flow
Buy
Level
4.8M
20-day SMA
Sell
Level
$3.64
Relative Strength Index (RSI14)
Sell
Level
46.38
ADX Line
Buy
Level
22.2
Williams %R
Neutral
Level
-60.6001
50-day SMA
Sell
Level
$3.68
MACD (12, 26)
Sell
Level
-0.08
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Neutral
Level
5M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7084)
Buy
CA Score
(Annual)
Level (0.0793)
Sell
Beneish M-Score
(Annual)
Level (-2.034)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.3286)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Life Healthcare Group Holdings Ltd is an international and diversified healthcare organization based in South Africa. The firm's segments include Hospitals that derive maximum revenue, Complementary services, Healthcare services, and Radiopharmaceutical products. The hospital services segment comprises all the acute hospitals and the complementary services segment includes mental health, acute rehabilitation, renal dialysis, oncology, and imaging services. The healthcare services segment comprises Life Nkanyisa and Life Health Solutions; and the radiopharmaceuticals represent the products developed by LMI across Europe, the UK, and the USA. Geographically, the company derives a majority of its revenue from its business in South Africa and the rest from International markets.
Stock Forecast FAQ
In the current month, LTGHY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LTGHY average analyst price target in the past 3 months is --.
-
Where Will Life Healthcare Group Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Life Healthcare Group Holdings share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Life Healthcare Group Holdings?
Analysts are divided on their view about Life Healthcare Group Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Life Healthcare Group Holdings is a Sell and believe this share price will rise from its current level to --.
-
What Is Life Healthcare Group Holdings's Price Target?
The price target for Life Healthcare Group Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LTGHY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Life Healthcare Group Holdings is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of LTGHY?
You can purchase shares of Life Healthcare Group Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Life Healthcare Group Holdings shares.
-
What Is The Life Healthcare Group Holdings Share Price Today?
Life Healthcare Group Holdings was last trading at $3.54 per share. This represents the most recent stock quote for Life Healthcare Group Holdings. Yesterday, Life Healthcare Group Holdings closed at $3.54 per share.
-
How To Buy Life Healthcare Group Holdings Stock Online?
In order to purchase Life Healthcare Group Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Will Booking Holdings Stock Split?
Booking Holdings, the travel and technology company that owns brands…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.06% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 7.03% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 0.89% over the past day.
